Immunization Newsbriefs
Link to Main Page
  Back Search the Site Send Your Feedbck  
Immunization Newsbriefs
Read Current Issue Online
Search Newsbriefs Archives
Subscribe to Email Online
Unsubscribe from Email Online
About NNii
Vaccine Information
Health Professionals
Policy Makers
Read Current Newsbriefs

DynPort Vaccine
Washington Post; E5


DynPort Vaccine, a joint venture between Computer Sciences Corp. and Porton International, conducted a study involving 150 patients and a diluted dose of the company's smallpox vaccine, called CCSV. The vaccine, even when diluted up to 50 times, produced positive results in all but one of the 100 people who had not previously received a smallpox vaccination. CCSV is also associated with fewer side effects when compared to patients receiving the traditional smallpox vaccine, Dryvax.

© Copyright National Network for Immunization Information. The information contained in the National Network for Immunization Information Web site should not be used as a substitute for the medical care and advice of your health care provider. There may be variations in treatment that your health care provider may recommend based on individual facts and circumstances.